Substandard/counterfeit antimicrobial drugs are a growing global problem. The most
common substandard/counterfeit antimicrobials include beta-lactams (among antibiotics) …

Poor‐quality medicines present a serious public health problem, particularly in emerging
economies and developing countries, and may have a significant impact on the national …

Importance Substandard and falsified medicines burden health systems by diverting
resources to ineffective or harmful therapies, causing medical complications and prolonging …

Little is known about the quality of antibiotics despite being in high demand globally. Thirty
five samples (27 brands) of the antibiotics amoxicillin (N= 20; 16 brands) and co-trimoxazole …

Counterfeit drugs can hurt patients and harm the pharmaceutical industry. In 2006, the
International Medical Products Anti-Counterfeiting Taskforce expressed a need to generate …

Objective To assess the quality of antibiotics sampled from authorised sales outlets (ATs)(ie
hospitals/health centres, pharmacies and licensed chemical shops) and unauthorised sales …

Antibiotics are among the most counterfeited anti‐infectious medicines in developing
countries. Amoxicillin is one of the commonly prescribed, affordable, and easily accessible …

Objectives: Counterfeit and substandard medicines pose a great threat to public health and
the economy worldwide. Reports suggest their prevalence is increasing and can no longer …

Antimicrobials, particularly antibiotics, are among the most common classes of drugs
reported as substandard and falsified (SF) in developing countries. Therefore, it is important …

Low-quality medicines deliver sub-optimal clinical outcomes and waste precious health
resources. It is important to ensure that public funds are spent on healthcare technologies …